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T cell factor 1 (TCF-1) is a transcription factor known
to act downstream of the canonical Wnt pathway
and is essential for normal T cell development. How-
ever, its physiological roles in mature CD8+ T cell
responses are unknown. Here we showed that TCF-1
deficiency limited proliferation of CD8+ effector
T cells and impaired their differentiation toward a
central memory phenotype. Moreover, TCF-1-defi-
cient memory CD8+ T cells were progressively lost
over time, exhibiting reduced expression of the anti-
apoptotic molecule Bcl-2 and interleukin-2 receptor
b chain and diminished IL-15-driven proliferation.
TCF-1 was directly associated with the Eomes allele
and the Wnt-TCF-1 pathway was necessary and
sufficient for optimal Eomes expression in naive
and memory CD8+ T cells. Importantly, forced
expression of Eomes partly protected TCF-1-defi-
cient memory CD8+ T cells from time-dependent
attrition. Our studies thus identify TCF-1 as a critical
player in a transcriptional program that regulates
memory CD8 differentiation and longevity.
INTRODUCTION
CD8+ T cells are critical in controlling infection by intracellular
pathogens including viruses and intracellular bacteria. Upon
encountering antigen, naive CD8+ T cells are activated and
clonally expand to a large quantity of effector cells equipped
with cytokines and cytolytic molecules. Most of the effectors
succumb to apoptosis during the contraction phase, and only
a small portion of them transition into memory CD8+ T cells,
capable of providing enhanced protection against the same
pathogen. The transition of effector to memory CD8+ T cells
is affected by extracellular stimuli including the strength and
timing of stimulatory signals derived from T cell receptor (TCR)-
antigen interactions, costimulation, and inflammatory cytokines
including interferons and IL-12 (Harty and Badovinac, 2008;
Kaech and Wherry, 2007; Williams and Bevan, 2007). Memory
CD8+Tcells are heterogeneous, consisting of at least twopheno-typically and functionally distinct subsets, i.e., effector memory
(Tem) and central memory (Tcm) T cells (Sallusto et al., 1999).
Whereas Tem cells patrol peripheral tissues, Tcm cells migrate
through secondary lymphoid organs and are capable of more
efficient homeostatic self-renewal and secondary proliferation
than Tem cells (Lefranc¸ois and Marzo, 2006; Wherry et al.,
2003). Generation and differentiation of memory T cells are
stipulated by intrinsic transcriptional programs. Inactivation of
T-bet, Blimp-1, and Id2 and forced expression of Bcl-6 increased
formation of Tcm cells (Cannarile et al., 2006; Ichii et al., 2004;
Intlekofer et al., 2007; Kallies et al., 2009; Rutishauser et al.,
2009). The longevity of memory T cells, in contrast, depends on
IL-15 (Schluns and Lefranc¸ois, 2003), and the IL-15 responsive-
ness is supported by eomesodermin-mediated positive regula-
tion of IL-2 receptor b chain (IL-2Rb) (Intlekofer et al., 2005).
T cell factor 1 (TCF-1) is a known effector transcription factor
downstream of the canonical Wnt pathway, functioning as either
transcriptional activator or repressor depending on its interact-
ing partners (Staal et al., 2008). The most studied coactivator,
b-catenin, is posttranscriptionally regulated by a multimolecular
‘‘destruction complex’’ containing two scaffolding proteins,
adenomatous polyposis coli and axis inhibition protein (Axin),
and two protein kinases, casein kinase I and glycogen synthase
kinase 3b (GSK3b). Phosphorylation of b-catenin by the kinases
marks it for proteosome-mediated degradation. Wnt stimulation
leads to inhibition of GSK3b and hence b-catenin stabilization.
The accumulated b-catenin translocates into the nucleus where
it displaces corepressor TLE-GRG (transducin-like enhancer-
Groucho-related gene) proteins and complexes with TCF-1 to
activate Wnt downstream genes (Staal et al., 2008). TCF-1 is
required for normal T cell development as shown by the fact
that inactivation of TCF-1 partly blocked thymocyte maturation
at several early stages (Verbeek et al., 1995), whereas TCF-1
deficiency did not affect proliferation and cytolytic activity of
mature T cells when assayed in vitro (Schilham et al., 1998).
However, several studies demonstrated that TCF-1-b-catenin
pathway is operative in naive or activated T cells (Jeannet
et al., 2008; Wu et al., 2007) and can be modulated by TCR
signaling (Xu et al., 2003). We and others have recently shown
that during CD8+ T cell responses, TCF-1 is dynamically regu-
lated, being downregulated in effectors and partly restored in
memory T cells (Willinger et al., 2006; Zhao et al., 2010). Simulta-
neous activation of TCR and the TCF-1-b-catenin Wnt path-
ways in vitro, however, prevented TCF-1 downregulation andImmunity 33, 229–240, August 27, 2010 ª2010 Elsevier Inc. 229
Figure 1. TCF-1 Deficiency Limits Expan-
sion of Antigen-Specific Effector CD8+
T Cells
(A) 500 WT or Tcf7/ OT-I T cells (CD45.2+) were
injected into CD45.1+ B6.SJL recipients, followed
by i.v. infection with 5 3 106 CFU actA-LM-Ova.
Kinetics of early responses of WT or Tcf7/ OT-I
cells were tracked in the PBLs, and their percent-
ages in CD8+ T cells are shown. Data are repre-
sentative of three independent experiments with
similar results (n R 3 for each time point). All
p values, including those in subsequent figures,
were determined with Student’s t test.
(B) Numbers of effector OT-I T cells in the spleen
on day 7 after infection. Data are pooled from
four independent experiments.
(C) Cell surface phenotypes of effector OT-I
T cells. Day 7 effector T cells were analyzed for
KLRG1, IL-7Ra, CD62L, and CD44 expression.
Percentages for KLRG1+, CD44+CD62Llo, and
CD44+CD62Lhi populations are shown. Shaded
histogram in IL-7Ra denotes its expression in
naive CD8+ T cells for a direct comparison with
the effector T cells.
(D) Production of effector molecules by effector
OT-I T cells. Splenocytes were isolated on day 7
after infection and incubated with Ova peptide
for 6 hr in vitro. The cells were sequentially surface
stained, fixed and permeabilized, and intracellu-
larly stained for IL-2, TNF-a, and granzyme B.
Gating of positive populations was based on
respective isotype controls. For (C) and (D), data
are representative from at least three independent
experiments with similar results.
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TCF-1 Regulates Longevity of CD8 Memory T Cellspromoted a CD8+ memory stem cell phenotype (Gattinoni et al.,
2009). In line with this, constitutive activation of the TCF-1-b-cat-
enin pathway in vivo favored generation of memory CD8+ T cells
(Zhao et al., 2010). These observations suggest that TCF-1-b-
catenin activity can be manipulated to positively regulate CD8+
memory. In contrast to its well-elucidated roles in T cell develop-
ment, it remains unknown what physiological roles TCF-1 may
play in regulating mature CD8+ T cells. This study revealed the
critical requirements of TCF-1 for CD8+ effector T cell expansion,
Tcm cell differentiation, and persistence of CD8+memory T cells.
RESULTS
TCF-1 Deficiency Limited CD8+ T Cell Response
to Listeria monocytogenes Infection
To circumvent potential alterations in TCR repertoire and
precursor frequency caused by TCF-1 (encoded by Tcf7) defi-
ciency (Verbeek et al., 1995), we crossed Tcf7/ to OT-I TCR
transgenic mice whose TCR recognizes the SIINFEKL epitope
from chicken ovalbumin. To mimic physiological precursor230 Immunity 33, 229–240, August 27, 2010 ª2010 Elsevier Inc.(a
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we transferred low numbers of WT or
Tcf7/ OT-I CD8+ T cells (expressing
CD45.2) into CD45.1+ B6.SJL recipients,
followed by infection with attenuated
Listeria monocytogenes expressing OvactA-LM-Ova). WT OT-I cells exhibited peak proliferation on
ay 7 after infection as tracked in peripheral blood leukocytes
BLs); however, proliferation of Tcf7/ OT-I cells reached
eak on day 6 and was reduced in magnitude by approximately
0% (Figure 1A). Tcf7/ OT-I effectors in the spleens were also
ecreased by about 50% (Figure 1B). Both WT and Tcf7/OT-I
ffectors were all positive for Ova-specific MHC-I tetramer and
ad similar capacity to produce interferon-g (IFN-g) when stimu-
ted in vitro (data not shown). Compared with WT controls,
cf7/ OT-I effectors exhibited similar downregulation of
-7Ra and CD62L, similar CD44 upregulation, and moderately
creased upregulation of KLRG1 (Figure 1C). Further, Tcf7/
ffectors showed similar tumor necrosis factor-a (TNF-a) pro-
uction, moderately increased granzyme B, and decreased
-2 production (Figure 1D). The perturbed effector proliferation
sulting from TCF-1 deficiency was further substantiated in
xperiments transferring Thy1.2+ WT or Tcf7/ OT-I (as test
ells) together with Thy1.1+ OT-I cells (as reference cells) into
D45 disparate recipients where the test and reference cells
ere exposed to the same host environment (Figures S1A and
Figure 2. Tcf7/ Memory CD8+ T Cells Are
Impaired in Secondary Expansion and in Differenti-
ation to a Tcm Cell Phenotype
(A) Frequency of early memory OT-I cells in PBLs. B6.SJL
recipients of either WT or Tcf7/ OT-I cells were infected
with actA-LM-Ova, and the percentage of CD45.2+ OT-I in
CD8+ T cells was determined on days 34–44 after
infection. Data are pooled results from two independent
experiments.
(B) Secondary expansion of memory CD8+ T cells in
the spleens. Sorted WT or Tcf7/ memory OT-I T cells
(6 3 103) were transferred into naive B6.SJL hosts,
followed by infection with 23 105 CFU of virulent LM-Ova.
The numbers of CD45.2+ OT-I cells in the spleens were
determined 6 days later. Data are means ± SD (n = 3).
Similar results were obtained when total splenocytes
containing equivalent numbers of WT or Tcf7/ memory
OT-I cells were transferred without sorting separation
(not shown).
(C) In vivo killing capacity of memory CD8+ T cells.
CD45.2+ splenocytes were differentially labeled with
CFSE. Ova peptide-pulsed CFSElo and non-peptide-
pulsed CFSEhi cells were injected at 1:1 ratio into naive
or immune chimeras (35 days after infection). The spleens
were harvested 4 hr later, and percentages of CFSElo and
CFSEhi cells in CD45.2+ splenocytes were determined.
Data are representative of two independent experiments
with similar results.
(D) Surface staining for CD62L, CCR7, IL-7Ra, and KLRG1
on antigen-specific memory CD8+ T cells. During days
75–85 after infection with actA-LM-Ova, splenocytes
fromWT or Tcf7/OT-I recipients were stained. Percent-
ages of CD62Lhi and CCR7+ subsets were shown in histo-
grams, with shaded histogram denoting isotype control.
Data are representative of 2–3 independent experiments
(nR 4).
(E) Intracellular detection of IFN-g, IL-2, TNF-a, and gran-
zyme B in memory CD8+ T cells. Splenocytes were stimu-
lated with Ova peptide for 6 hr, followed by surface and
intracellular staining. Gating of positive populations was
based on respective isotype controls. All data are repre-
sentative of three independent experiments (nR 5).
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TCF-1 Regulates Longevity of CD8 Memory T CellsS1B available online). Taken together, Tcf7/ CD8+ T cells can
be activated to acquire effector function but showed reduced
magnitude of proliferation.
By measuring 50-bromo-20-dexoxy-uridine (BrdU) uptake, we
found that Tcf7/ OT-I effectors proliferated similarly to WT
during days 4–5 after infection but their proliferation was not sus-
tained during days 6–7 (Figures S1C and S1D). On the other
hand, WT and Tcf7/ effectors at days 5 and 7 exhibited similar
rates of apoptosis, as measured by caspase-3 and -7 activation
(Figure S1E), in key contrast to increased caspase-3 and -7
activity in Tcf7/ thymocytes (Figure S1F). Our results demon-
strate that TCF-1 is essential for sustained proliferation of
effector T cells, highlighting a distinct regulatory role of TCF-1
in activated mature T cells.Immunity 33, 2Tcf7/Memory T Cells Were Impaired in
Secondary Expansion but Not Cytotoxity
Tcf7/ effector OT-I T cells contracted similarly
to WT effectors, giving rise to proportionally
lower frequency of early memory CD8+ T cellsin the PBLs (Figure 2A). Memory T cells are characteristic of
enhanced proliferation upon reencounter of the same pathogen.
To measure the secondary expansion on a per cell basis, we
transferred the same number of sorted WT or Tcf7/ OT-I
memory T cells into naive B6.SJL hosts. After infection with viru-
lent LM-Ova, secondary proliferation of Tcf7/ memory T cells
was greatly diminished in the spleens (Figure 2B), indicating
that secondary effectors are more dependent on TCF-1 for
expansion compared with the primary response.
To assess the cytolytic activity of WT and Tcf7/ memory
CD8+ T cells, we used a short-term in vivo killing assay that does
not involve extensive secondary expansion (Barber et al., 2003).
To this end, we transferred 2500 WT or Tcf7/ OT-I cells prior
to LM-Ova infection so that the endogenous antigen-specific29–240, August 27, 2010 ª2010 Elsevier Inc. 231
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TCF-1 Regulates Longevity of CD8 Memory T CellsT cells in the B6.SJL hosts were outcompeted (Badovinac et al.,
2007) and chose the recipients containing similar frequencies
of WT and Tcf7/ early memory OT-I T cells for the assay.
Whereas the killing target cells that were Ova peptide pulsed
and labeled with low concentration of carboxyfluorescein succi-
nimidyl diester (CFSE) were not affected in naive mice, they
were substantially eliminated in the immune recipients of either
WT or Tcf7/ OT-I cells (Figure 2C). Thus, lack of TCF-1 did not
detectably alter the cytolytic activity of memory CD8+ T cells.
Tcf7/ Memory CD8+ T Cells Exhibited Predominantly
a Tem Cell Phenotype
Effector CD8+ T cells are generally IL-7Ralo and KLRG1hi, but
IL-7Ra upregulation and KLRG1 downregulation are associated
with differentiation of effectors to long-lived protective memory
CD8+ T cells (Joshi et al., 2007). Tcm and Tem memory T cells
have distinct expression of homing receptors including CD62L
and CCR7 (Sallusto et al., 1999). Analysis of Tcf7/ memory
CD8+ T cells at 75–85 days after infection revealed that substan-
tially fewer cells expressed CD62L and CCR7 than WT controls
and that most of them retained high expression of KLRG1
(Figure 2D). In contrast, IL-7Ra was upregulated similarly in
both WT and Tcf7/ memory T cells (Figure 2D). Upon peptide
stimulation in vitro, WT and Tcf7/ memory T cells were both
capable of producing IFN-g and TNF-a, and increased portion
of Tcf7/ CD8+ memory expressed granzyme B (Figure 2E).
Importantly, IL-2 production, another characteristic feature of
Tcm cells (Wherry et al., 2003), was impaired in Tcf7/memory
T cells (Figure 2E). Thus, Tcf7/ memory T cells predominantly
manifested an effector memory phenotype even at >75 days
after infection, indicating an essential role of TCF-1 in differenti-
ation of Tcm cells. The intrinsic requirements of TCF-1 for
memoryCD8+differentiationwere further substantiated via a viral
infectionmodel, where Tcf7/memory OT-I T cells generated in
response to infection with vaccinia virus expressing Ova (VacV-
Ova) exhibited similarly predominant Tem cell phenotypes
(Figures S2A and S2B).
Tcf7/mice are moderately lymphopenic, and Tcf7/ T cells
show increased portion of CD44hi subset, probably resulting
from increased homestatic proliferation (Schilham et al., 1998).
Tcf7/ OT-I T cells retained this phenotype and were positive
for CD62L, IL-7Ra, and CCR7 but negative for KLRG1
(Figure S2C). Whereas CD44hi CD8+ T cells produced IFN-g after
brief TCR stimulation (Cho et al., 2000; Goldrath et al., 2000), the
TCR-stimulated IFN-g production was negligible in both WT and
Tcf7/ CD44lo CD8+ T cells (Figure S2D). Thus, Tcf7/ CD44lo
T cells manifested phenotypic and functional features that
resembled naive T cells. To exclude the possibility that the
increased CD44hi subset in Tcf7/ T cells may account for the
defects observed above, we sorted CD62L+CD44lo naive OT-I
cells from WT and Tcf7/ spleens and repeated the adoptive
transfer and LM-Ova infection experiments. Tcf7/ OT-I effec-
tors in PBLs derived from the naive precursors were also limited
in proliferation (Figure S2E). Further, the Tcf7/ memory CD8+
T cells derived from naive precursors were also predominantly
Tem cells, showing reduced CD62L expression and IL-2 produc-
tion (Figures S2F and S2G). These findings further corroborated
an intrinsic requirement of TCF-1 for Tcm cell differentiation, in
spite of previous exposure to a lymphopenic environment.232 Immunity 33, 229–240, August 27, 2010 ª2010 Elsevier Inc.Progressive Loss of Tcf7/ CD8+ Memory T Cells
Resulting from Diminished Responsiveness to IL-15
In addition to defective secondary expansion and Tcm cell differ-
entiation, we noted that Tcf7/ memory CD8+ T cells in the
spleens underwent progressive loss over time, in contrast to
relatively stably maintained WT CD8+ memory (Figure 3A). The
decrease was not due to skewed tissue distribution, because
Tcf7/ memory CD8+ T cells were diminished similarly in bone
marrow cells and did not accumulate in livers or lungs (Fig-
ure 3B). In fact, the decrease in Tcf7/ CD8+ memory was
most evident in lymph nodes (Figure 3B), consistent with its
reduced CD62L and CCR7 expression and hence homing
defects to secondary lymphoid tissues. IL-7 and IL-15 are known
to be critical for maintaining memory CD8+ T cells (Schluns and
Lefranc¸ois, 2003). Although no apparent differences in IL-7Ra
and IL-15Ra were observed, IL-2Rb, a shared receptor subunit
between IL-2 and IL-15, was decreased in expression in Tcf7/
memory T cells (Figure 3C). Consistent with the reported roles of
IL-15 in homeostatic proliferation and promoting survival of
memory T cells (Berard et al., 2003; Prlic et al., 2002), Tcf7/
memory T cells showed diminished BrdU uptake (Figure 3D)
and Bcl-2 expression (Figure 3E), and exhibited substantially
reduced IL-15-driven proliferation compared with WT cells (Fig-
ure 3F). Importantly, reduced expression of IL-2Rb and Bcl-2
was observed in Tcf7/memory OT-I cells that were generated
in response to VacV-Ova infection (Figure S3A) and from naive
precursors (Figure S3C), supporting the fact that TCF-1 is intrin-
sically required for sustaining IL-15 responsiveness in CD8+
memory.
Wnt-TCF-1 Pathway Was Necessary and Sufficient
to Induce Eomesodermin Expression
To gain mechanistic insights into the role of TCF-1 in maintaining
memory CD8+ T cells, we performed transcriptomic analysis
on sorted WT and Tcf7/ memory OT-I cells. By the setting of
p < 0.05 for significantly differential expression, 526 genes
were upregulated and 776 genes downregulated for >1.5-fold
because of TCF-1 deficiency. Functional annotation via DAVID
(the Database for Annotation, Visualization, and Integrated
Discovery) bioinformatics resources (Huang da et al., 2009)
revealed that TCF-1 controls a wide spectrum of biological
functions in memory T cells, including transcriptional regulation,
cell cycle progression, and apoptosis, in addition to CD8+
effector molecules, cytokines, chemokines, and their receptors
(Table S1). In line with our functional and phenotypic analyses,
granzymes A and B and KLRG1 were among the top 20 upregu-
lated genes, and perforin transcript was increased by 1.45-fold in
Tcf7/ memory T cells (p = 0.024, Figure 4A). Additionally,
Tcf7/ memory T cells had decreased transcripts of CD62L
(encoded by Sell), CCR7, and IL-2Rb (Figure 4A, Il2rb transcript
reduced by 30%, p = 0.038). Eomesodermin (Eomes) and c-Myc
were among the most downregulated genes in Tcf7/ memory
CD8+ T cells (Figure 4A). Compared with another T-box factor,
T-bet, Eomes has been shown to directly bind to 50-regulatory
regions in the Il2rb gene, more effectively enhance IL-2Rb
expression, and confer IL-15 responsiveness to memory CD8+
T cells (Intlekofer et al., 2007). By intranuclear staining, we found
that the protein expression of Eomes but not T-bet was substan-
tially diminished in Tcf7/ memory CD8+ T cells (Figure 4B).
Figure 3. Long-Term Maintenance and IL-15 Responsiveness of Memory CD8+ T Cells Depend on TCF-1
(A) Progressive loss of Tcf7/memory CD8+ T cells. B6.SJL recipients of WT or Tcf7/OT-I cells were sacrificed on indicated days after infection and memory
OT-I T cells in the spleens were enumerated. Data are means ± SD from at least three independent experiments.
(B) Tissue distribution of memory CD8+ T cells. During 75–85 days after infection, frequency of memory OT-I in CD8+ T cells was determined in indicated tissues.
Data are pooled from two independent experiments.
(C) Expression of IL-15Ra and IL-2Rb on memory CD8+ T cells. Memory OT-I cells were surface stained, and percentages of positive cells were shown in repre-
sentative histograms based on isotype staining (shaded). Cumulative results from 2–4 experiments were shown on the right panel as DMFI, the difference of MFI
(mean fluorescent intensity) values of antibody- and isotype-stained entire cell populationswithout positivity gating. The same approachwas used to present data
in (E) and Figures 4B, 5E, and 7C.
(D) BrdU uptake in memory CD8+ T cells. The B6.SJL recipients were i.p. injected with BrdU on day 70 after infection and fed with BrdU in drinking water for
1 week. The percentage of BrdU+ population was shown in representative contour plots (on the left) or cumulative data from three independent experiments
(on the right).
(E) Expression of Bcl-2 in memory CD8+ T cells. Memory OT-I cells were intracellularly stained for Bcl-2. Data are either representative of or pooled from three
independent experiments.
(F) Proliferation of memory CD8+ T cells in response to IL-15. Memory OT-I cells were labeled with CFSE and cultured in the presence of IL-15 (50 ng/ml).
The shaded histogram denotes the CFSE level in cells cultured without IL-15, and the percentage denotes actively dividing cells. Representative data after
4-day culture are shown for two independent experiments with similar results (n = 3).
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TCF-1 Regulates Longevity of CD8 Memory T CellsSimilarly diminished Eomes expression was observed in Tcf7/
memory OT-I T cells generated in response to VacV-Ova infec-
tion (Figure S3B) or from naive precursors (Figure S3D).
To determine whether Eomes expression is responsive to
activation of Wnt signaling, we used 6-bromo-substituted
indirubin-acetoxime (BIO-acetoxime), a specific inhibitor of
GSK-3b, to block b-catenin phosphorylation and degradation
(Meijer et al., 2004). BIO-acetoxime treatment stabilized b-cate-nin in naive CD8+ T cells as expected and induced the expres-
sion of Eomes but not T-bet (encoded by Tbx21) (Figures S4A
and S4B). c-Myc acts at least partly downstream of IL-15 in regu-
lating homeostasis of memory CD8+ T cells (Bianchi et al., 2006).
Although reported to be a Wnt target gene in human colorectal
cancers (He et al., 1998), c-Myc did not respond to Wnt activa-
tion in mature T cells, suggesting that Wnt-responsive genes
could be highly cell context dependent (Figure S4B). TreatmentImmunity 33, 229–240, August 27, 2010 ª2010 Elsevier Inc. 233
Figure 4. TCF-1 Is Necessary for Optimal Eomes Expression
(A) Transcriptomic analysis revealed expression changes in genes that are critical for regulating CD8+ T cell activities. Day 70–80 memory CD8+ T cells were
sorted from three WT or three Tcf7/ OT-I recipients and subjected to microarray analysis via Mouse GENE 1.0 ST arrays. Heatmaps of select genes and
color-coded scales are shown.
(B) Eomes but not T-bet was expressed at lower levels in Tcf7/memory CD8+ T cells. Memory CD8+ T cells (>70 days after infection) were intranuclearly stained
for Eomes and T-bet. Shown on left are representative histograms with percentages of positive subsets, and on right are cumulative DMFI data from three inde-
pendent experiments.
Immunity
TCF-1 Regulates Longevity of CD8 Memory T Cellsof sorted memory OT-I cells with BIO-acetoxime also induced
Eomes expression but had little effects on T-bet and c-Myc
(Figure 5A). In contrast, treatment with N-methylated BIO
(MeBIO), an inactive analog of BIO-acetoxime, neither stabilized
b-catenin nor apparently altered Eomes and other genes’
expression (Figure 5A; Figure S4).
We next investigated whether naive and memory CD8+ T cells
are responsive to bona fide Wnt ligands. Consistent with pre-
vious observations that both resting and activated human
T cells express multiple Fzd receptors (Wu et al., 2007), our
microarray analysis showed that WT memory CD8+ T cells
expressed high amounts of Fzd5 and Fzd9, Lrp5 and Lrp6 core-
ceptors, and Dvl molecules connecting Fzd-Lrp receptor and
the b-catenin destruction complexes (Figure S4C), most of which
were not apparently affected by TCF-1 deficiency. Thus,
memory CD8+ T cells are equipped with Wnt-responsive recep-
tors. Axin2 has been suggested to be a universal Wnt-induced
target gene as a negative regulator of the Wnt pathway (Jho
et al., 2002; Lustig et al., 2002). We stimulated naive CD8+
T cells with Wnt3a, which has been shown to promote prolifera-
tion of hematopoietic stem cells via accumulation of b-catenin
(Willert et al., 2003). We confirmed induction of Axin2 by Wnt3a
and found that Wnt3a induced Eomes but not T-bet or c-Myc
expression in naive CD8+ T cells (Figure 5B). Further, the induc-
tion of Axin2 and Eomes by Wnt3a was diminished in Tcf7/
CD8+ T cells, indicating its TCF-1 dependency (Figure 5B). The
remaining induction of Eomes in Tcf7/ CD8+ cells may be
ascribed to the presence of another Wnt effector transcription
factor, lymphoid enhancer-binding factor 1 (LEF-1).
Eomes expression was reported to increase in effector T cells
(Intlekofer et al., 2007). We found that TCR stimulation of naive234 Immunity 33, 229–240, August 27, 2010 ª2010 Elsevier Inc.T cells did not detectably alter Eomes expression, at least during
the observation period when the induction by Wnt3a was
apparent (Figure 5C), suggesting that Eomes can be induced
rapidly by Wnt ligand stimulation in the absence of TCR-derived
signals. Interestingly, Wnt3a-induced Eomes upregulation was
diminished when naive T cells were stimulated by the combina-
tion of Wnt and TCR (Figure 5C). This is probably due to down-
regulation of TCF-1 in naive T cells by TCR stimulation, regard-
less of whether Wnt3a is present (Figure 5C).
We further validated that Eomes can be induced by Wnt3a in
memory CD8+ T cells (Figure 5D), although the induction was
somehow smaller compared with that seen in naive T cells.
This is probably explained by the fact that memory CD8+
T cells express higher amounts of Eomes (Intlekofer et al.,
2007) but lower amounts of TCF-1 and LEF-1 than naive
T cells (Willinger et al., 2006; Zhao et al., 2010), or alternatively
Wnt3a may not be the most potent Wnt ligand acting on memory
T cells. In key contrast to naive T cells, TCR stimulation of
memory CD8+ T cells did not apparently downregulate TCF-1
or diminishWnt-mediated induction of Eomes (Figure 5D). These
findings suggest distinct cross-talk between Wnt and TCR
signaling pathways in naive and memory T cells, which merits
future investigations.
We recently demonstrated that constitutive activation of Wnt
signaling pathway, via transgenic expression of p45 TCF-1 and
stabilized b-catenin, favors generation of CD8+ memory T cells
(Zhao et al., 2010). In memory T cells generated in the double
transgenic mice (dTg), protein expression of Eomes was
elevated and T-bet expression was slightly decreased, if any
(Figure 5E). These in vivo data further support the notion that in
memory CD8+ T cells, the Wnt-TCF-1 pathway is necessary
Figure 5. Activation of the CanonicalWnt/TCF-1/b-Catenin Pathway
Is Sufficient to Induce Eomes Expression
(A) Inhibition of GSK3b induces Eomes expression in memory CD8+ T cells.
Day 60 memory OT-I T cells were sorted from LM-Ova-infected B6.SJL recip-
ients and treated with DMSO, BIO-acetoxime (BIO), or N-methylated BIO
(MeBIO) for 12 hr. The expression of select genes was quantitatively deter-
mined, and all normalized to the samples treated with DMSO.
(B) Induction of Axin2 and Eomes by Wnt3a in naive CD8+ T cells. Freshly
isolated naive CD8+ T cells from WT or Tcf7/ mice were exposed to
Wnt3a conditioned or control medium for 3 hr. Gene expression was quan-
titatively determined and then normalized to the control medium-treated
samples.
Immunity
TCF-1 Regulates Longevity of CD8 Memory T Cellsand sufficient for inducing the optimal expression of Eomes tran-
scription factor, which in turn positively regulates IL-2Rb expres-
sion and IL-15 responsiveness.TCF-1 Bound to Regulatory Sequences in the Eomes
Gene In Vivo
To investigate whether TCF-1 is directly associated with the
Eomes gene, we surveyed a 6 kb noncoding DNA sequence
flanking the Eomes transcription initiation site (5 kb to +1 kb)
for the core consensus TCF-1 binding motif ‘‘CTTTG’’ (van de
Wetering and Clevers, 1992). Among a total of 20 TCF-1 motifs
found in the 50-regulatory region, 6 were conserved among
different species (Figure 6A; Figure S5). Eight TCF-1 motifs
(termed T1 to T8) within 1.5 kb to +2.6 kb of the Aixn2 gene
were previously defined to contribute to its Wnt responsiveness
(Jho et al., 2002). Because Axin2 was induced by Wnt3a stimu-
lation in mature CD8+ T cells, we used two clusters of TCF-1
motifs (T2/3 and T7/8) in the Axin2 gene (corresponding to
its promoter and an intron region, respectively) as potential
positive controls. Rag2 is silenced in mature T cells and T-bet
does not respond to Wnt, so we therefore used the Rag2
promoter (0.6+0.7 kb) and a Tbx21 50-regulatory region
(2.61.2 kb) containing no conserved TCF-1 motifs as nega-
tive controls. Because Eomes is inducible by activated Wnt
signaling in both naive and memory T cells as shown above,
we used naive CD8+ T cells to obtain sufficient cells for chro-
matin immunoprecipitation (ChIP). As shown in Figure 6B,
enriched TCF-1 binding was found in the two Axin2 regulatory
clusters, six conserved 50 consensus ‘‘CTTTG’’ motifs in Eomes
(with first three in ‘‘cluster a’’ and the other three as ‘‘elements
b-d’’), but not in the Tbx21 gene or 10 kb and +3 kb regions
in the Eomes gene, although both locations in the Eomes allele
harbored conserved TCF-1 motifs. Importantly, all the enriched
TCF-1 bindings were abrogated when Tcf7/ CD8+ T cells
were used (Figure 6B). Additionally, ChIP with another irrelevant
antibody against transcription factor GA binding protein did not
enrich TCF-1-associated sequences, consistent with ChIP-seq
data showing no binding of GA binding protein in Eomes or
Axin2 gene loci (data not shown). These results demonstrate
direct and specific binding of TCF-1 with multiple cis-regulatory
sequences in the Eomes and Axin2 loci.(C) Effect of Wnt and TCR stimulation in naive CD8+ T cells. WT naive CD8+
T cells were stimulated with Wnt3a and/or plate-bound anti-CD3 (5 mg/ml) +
soluble anti-CD28 (1 mg/ml) for 3 hr, and gene expression was quantitatively
determined and normalized as in (B).
(D) Effect of Wnt and TCR stimulation in memory CD8+ T cells. Memory CD8+
T cells were isolated as in (A) and stimulated as in (C), and gene expression
was quantitatively determined. For (A)–(D), data are representative of at least
two independent experiments with similar results (n R 4).
Data in (A)–(D) are means ± SD.
(E) Increased Eomes expression in memory CD8+ T cells in the presence of
constitutively active Wnt signaling. Double transgenic (dTg) mice with forced
expression of p45 TCF-1 and stabilized b-catenin and their WT littermates
were infected with actA-LM-Ova. During days 45–55 after infection, memory
CD8+ T cells were identified by intracellular detection of IFN-g after 6 hr
Ova peptide stimulation, and Eomes or T-bet expression was determined in
IFN-g+ CD8+ T cells. Data shown are representative histograms (on the left)
and cumulative DMFI from 2–3 independent experiments (on the right).
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Figure 6. TCF-1 Is Directly Associatedwith Regulatory Sequences in
the Eomes Gene
(A) Schematic showing locations of conserved consensus TCF-1 binding
motifs in the 50-regulatory region of the Eomes gene. Multiple species conser-
vation from the UCSC genome browser is shown on the top, and locations of
each conserved TCF-1 motif and corresponding PCR amplicon are marked
below. The three TCF-1 motifs found in 3.5 kb were collectively defined as
‘‘cluster a,’’ and the other three relatively scattered motifs were referred to
as ‘‘element b to d.’’ See Figure S5 for the sequence alignments among
different species.
(B) TCF-1 binds to the Eomes regulatory sequences in vivo. Chromatin frag-
ments from WT or Tcf7/ splenic CD8+ T cells were immunoprecipitated
with a TCF-1 antibody or a control IgG. Enrichment of each segment was
determined with quantitative PCR and normalized to the Rag2 promoter
region. Data are representative of three independent ChIP experiments with
each sample measured in duplicates or triplicates.
(C and D) TLE-GRG (C) and b-catenin (D) co-occupy Eomes regulatory
sequences with TCF-1. Chromatin fragments from splenic CD8+ T cells of
WT or b-catenin transgenic mice were immunoprecipitated with TLE-GRG or
b-catenin antibody, respectively. Enrichment of each segment was quantita-
tively measured, and data are representative of two independent experiments
with similar results.
Data in (B)–(D) are means ± SD.
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TCF-1 pathway, we performed ChIP with an antibody recog-
nizing all four isoforms of TLE-GRG, the corepressor proteins236 Immunity 33, 229–240, August 27, 2010 ª2010 Elsevier Inc.interacting with TCF-1 in the absence of active Wnt signaling.
We also performed ChIP with a b-catenin antibody on transgenic
CD8+ T cells expressing stabilized b-catenin. All the TCF-1-
bound motifs were enriched by either TLE-GRG or b-catenin
antibody (Figures 6C and 6D), indicating the co-occupancy of
TLE-GRG or b-catenin with TCF-1 on regulatory sequences in
the Eomes gene. Taken together, these findings identified
Eomes as a direct Wnt target gene in mature CD8+ T cells.Forced Expression of Eomes Protected
Time-Dependent Loss of Tcf7/ Memory T Cells
To demonstrate that Eomes is functionally important in medi-
ating regulation of memory T cell maintenance by TCF-1, we
introduced the Eomes cDNA into primed WT or Tcf7/ OT-I
T cells by using MigR1 bicistronic retroviral vector with GFP
as an expression indicator. The retrovirally transduced OT-I
T cells were then adoptively transferred into naive mice, followed
by LM-Ova infection (Figure S6A; Joshi et al., 2007). We hypoth-
esized that if Eomes is a key mediator of TCF-1-dependent
persistence of memory CD8+ T cells, forced expression of
Eomes should confer protection to Tcf7/ memory OT-I
T cells. Throughout effector to early and late memory phases,
when infected with MigR1 control retrovirus, the percentages
of GFP-positive WT or Tcf7/ OT-I T cells remained relatively
stable, indicating that retroviral infection itself or GFP expression
did not detectably alter the behavior of effector and memory
CD8+ T cells (Figures 7A and 7B). The GFP+ subset was also
stably sustained in WT OT-I cells infected with MigR1-Eomes
retrovirus. In key contrast, the portion of GFP+ Tcf7/OT-I cells
that had forced expression of Eomes was elevated in early
memory T cells compared with effector phase and continued
to increase in late memory stage (Figures 7A and 7B), indicating
that Eomes-expressing Tcf7/memory T cells gained a relative
self-renewal and/or survival advantage whereas those without
Eomes continues to disappear over time. We confirmed
increased expression of Eomes in GFP+ WT or Tcf7/ memory
OT-I T cells infected with MigR1-Eomes (Figure S6B). We further
determined that forced expression of Eomes substantially
increased IL-2Rb expression in Tcf7/ memory CD8+ T cells,
although it did not have an evident effect on IL-2Rb expression
in WT memory CD8+ T cells (Figure 7C). Additional phenotypic
and functional analyses showed that increased Eomes expres-
sion in Tcf7/ T cells did not improve generation of IL-2-
producing CD62L+ Tcm cells (Figure S6C). Nonetheless, forced
expression of Eomes can at least partly restore IL-2Rb expres-
sion in TCF-1-deficient memory T cells and protect them from
time-dependent attrition.DISCUSSION
TCF-1 is known to be important for normal thymocyte develop-
ment, and loss of TCF-1 partly blocked T cell development at
several early stages (Verbeek et al., 1995). Whereas deficiency
in LEF-1, another Wnt effector transcription factor, did not cause
detectable T cell defects, a combination of hypomorphic TCF-1
alleles and LEF-1 null alleles completely arrested T cell develop-
ment at the immature single positive stage resulting from failure
of TCRa rearrangements (Okamura et al., 1998). These
Figure 7. Forced Expression of Eomes Protects Tcf7/ Memory CD8+ T Cells from Attrition
(A) Representative flow profiles of retrovirally transduced effector (day 7) and memory (day 70+) CD8+ T cells. Percentages of GFP+ subsets, infected with either
MigR1 control retrovirus or Eomes-expressing retrovirus, in CD8+CD45.2+ cells are shown from two independent experiments (nR 4).
(B) Fold changes of GFP+ cells during OT-I response. GFP+ percentage in each recipient mouse on day 7 after infection was arbitrarily set to 1, and that in each
mouse during the memory phase was normalized to day 7 to calculate the fold changes. Data are means ± SD of at least four individual recipients for each group
(pooled from two independent experiments).
(C) IL-2Rb expression in retrovirally infected WT and Tcf7/ memory CD8+ T cells. Splenocytes were isolated from recipients of retrovirally infected WT or
Tcf7/ OT-I T cells on day 40 after LM-Ova infection, and IL-2Rb expression was determined on GFP+CD45.2+CD8+ T cells with representative histograms
and cumulative DMFIs shown from two independent experiments.
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and LEF-1 in developing T cells. Our current studies revealed
that TCF-1 is a key player in regulating mature T cell responses
at several different phases and that TCF-1 may have both
overlapping and nonredundant roles with LEF-1 during these
processes. TCF-1 deficiency limited primary expansion of
effector T cells, but this effect was relatively moderate. In addi-
tion, TCF-1 appeared to be dispensable for cytolytic activity of
memory CD8+ T cells. During revision of the current manuscript,
Jeannet et al. (2010) reported that the proliferation of Tcf7/
CD8+ effectors and cytolytic activities of Tcf7/ memory CD8+
T cells were relatively unaffected via a lymphocytic choriomenin-
gitis (LCMV) infection model. These are probably explained by
compensatory effect by LEF-1. In contrast, the requirements of
TCF-1 in Tcm cell differentiation and longevity are nonredundant
with LEF-1, although TCF-1 and LEF-1 are both expressed in
memory T cells (Zhao et al., 2010). Additionally, the secondary
expansion of Tcf7/ memory CD8+ T cells was more severely
impaired in both LM and LCMV infection models (Jeannet
et al., 2010), indicating a unique and strong dependence on
TCF-1 inmemory CD8+ T cells. In linewith this, a distinct function
of TCF-1 has also been recently described in differentiation of
CD4+ T cells to a Th2 cell fate (Yu et al., 2009).A transcriptional regulatory network has been elucidated that
determines the fate of activated B cells to antibody-secreting
plasma cells and long-lived memory B cells. In the network, B
lymphocyte-induced maturation protein-1 (Blimp-1) and Bcl-6
are two key transcription factors thatmutually repress each other
(Martins and Calame, 2008). A similar transcription network
regulating CD8+ effectors to central memory fate is beginning
to emerge from several recent studies. Inactivation of T-bet,
Blimp-1, and Id2 and forced expression of Bcl-6 increased
formation of Tcm cells (Cannarile et al., 2006; Ichii et al., 2004;
Intlekofer et al., 2007; Rutishauser et al., 2009). Gene expres-
sion analysis showed that T-bet difficiency is associated with
increased expression of Eomes and that loss of Blimp-1 resulted
in downregulation of T-bet and Id-2 and upregulation of Eomes
and Bcl-6 (Intlekofer et al., 2007; Kallies et al., 2009; Rutishauser
et al., 2009). Our current study revealed that ablation of TCF-1
impaired Tcm cell formation. Coupled with our previous finding
that forced expression of TCF-1 and stabilized b-catenin gave
rise to increased numbers of IL-2-producing memory CD8+
T cells (Zhao et al., 2010), TCF-1 has a positive regulatory role
in Tcm cell differentiation. In line with this notion, TCF-1 expres-
sion was upregulated approximately 10-fold in Blimp-1-deficient
CD8+ effector cells (Rutishauser et al., 2009). Collectively, alongImmunity 33, 229–240, August 27, 2010 ª2010 Elsevier Inc. 237
Immunity
TCF-1 Regulates Longevity of CD8 Memory T Cellswith other transcription factors, TCF-1 contributes to an intricate
yet interactive gene regulatory network to collaboratively pro-
gram Tcm cell formation.
Wnt-responsive genes were previously reported in double-
negative thymocytes, including transcription factors c-Jun and
c-Fos (Staal et al., 2004), whereas direct binding of TCF-1 to
regulatory elements of these genes in vivo has not been demon-
strated in thymocytes. In mature T cells, information on Wnt
targets is scarce. Recently, it has been shown via ChIP that
TCF-1 can bind to the proximal promoter of Gata3 in CD4
T cells to promote a Th2 cell fate (Yu et al., 2009) and to the
promoters of matrix metalloproteinases 2 and 9 genes in human
T cells to facilitate T cell transmigration through epithelial cells
(Wu et al., 2007). All the aforementioned Wnt-responsive or
TCF-1-b-catenin-bound genes were not markedly altered in
expression between WT and TCF-1-deficient memory CD8+
T cells. In addition, c-Myc, another known Wnt target in human
colorectal cancers (He et al., 1998), was decreased in Tcf7/
memory T cells but its expression did not respond to stimulation
by Wnt3a or b-catenin stabilization. These findings highlight that
TCF-1-regulated genes are highly dependent on cell types and
their developmental stages for T cells in particular. Axin2 has
been characterized to be a Wnt target gene in many other tissue
and cell types (Jho et al., 2002; Lustig et al., 2002). In the current
study of mature CD8+ T cells, we found that Axin2 was induced
by Wnt3a stimulation in a TCF-1-dependent manner and further
showed direct association of TCF1 with the Axin2 allele in vivo.
With Axin2 as a positive control, we demonstrated direct and
specific binding of TCF-1 to six conserved consensus
sequences in the Eomes 50-regulatory region. The relevance of
these TCF-1 binding sites in Wnt signaling was supported by
the co-occupancy by TLE-GRG corepressor proteins in the
absence of Wnt stimulation and by b-catenin upon stabilization.
Along with TCF-1-dependent induction of Eomes by Wnt, these
findings collectively identified Eomes as a direct target of the
Wnt-TCF-1 pathway in mature CD8+ T cells.
It is well known that TCF-1 activity is regulated by Wnt ligands
that stabilize the coactivator b-catenin and lead to displacement
of TLE-GRG corepressors (Staal et al., 2008). Recent studies
suggest that the expression of TCF-1 in T cells can bemodulated
by signals derived from TCR and cytokines. In vivo activation of
T cells downregulated TCF-1 in both mice and humans (Willinger
et al., 2006; Zhao et al., 2010). This is also true for in vitro TCR-
stimulated T cells; however, when combined with pharmacolog-
ically stabilized b-catenin, TCF-1 downregulation was blocked
(Gattinoni et al., 2009). In addition, TCF-1 expression can be
influenced by cytokines when primed in vitro, being induced by
IL-21 but sustained at a low level by IL-2 and IL-15 (Hinrichs
et al., 2008). Furthermore, b-catenin stabilization by TCR stimu-
lation was described in thymocytes and CD4 T cells (Xu et al.,
2003). Collectively, it is reasonable to assume that TCF-1-b-cat-
enin pathway can integrate signals from Wnt ligands, TCR
engagement, and various cytokines during T cell responses,
especially during effector expansion and transition to memory
T cells. Detailed dissection of the contribution of individual
pathways to regulating TCF-1 activity and expression awaits
future investigations. Nevertheless, data from the current study
suggest a direct Wnt involvement in the persistence of memory
CD8+ T cells. We demonstrated that activation of the Wnt238 Immunity 33, 229–240, August 27, 2010 ª2010 Elsevier Inc.pathway by either GSK3b inhibition or Wnt3a stimulation, in the
absence of signals from TCR or cytokines, induced the expres-
sion of Eomes in both naive and memory CD8+ T cells. In vivo,
forced expression of TCF-1 and stabilized b-catenin expanded
the CD8+ memory T cell pool (Zhao et al., 2010). By the time
when memory T cells are generated in response to acute viral
or bacterial infection, inflammatory cytokines produced during
early immune responses have subsided, and it has been demon-
strated that persistence of memory CD8+ T cells does not
depend on signaling from MHC class I ligands but rather on
IL-15 (Jabbari and Harty, 2005; Murali-Krishna et al., 1999;
Schluns and Lefranc¸ois, 2003; Williams and Bevan, 2007). In
the absence of TCR stimulation, the endogenous IL-15 signal
alone may not affect TCF-1 expression in memory CD8+ T cells
in vivo, and this notion is supported by our recent observation
thatmemory T cells express higher amounts of TCF-1 than effec-
tors (Zhao et al., 2010). Thus, TCF-1-b-catenin-mediated regula-
tion of Eomes expression in memory CD8+ T cells is more likely
ascribed to Wnt, rather than TCR or cytokine-derived signals.
Whereas the identity and source of Wnt ligands that contribute
to the longevity of CD8+ memory remain to be elucidated, it
has been shown that macrophages and in vitro differentiated
dendritic cells can produce Wnt7b and Wnt5a, respectively
(Lehtonen et al., 2007; Lobov et al., 2005), and that multiple
Wnt transcripts includingWnt 1, 2B, 4, 5A, and 8Bwere detected
in vascular endothelial cells (Wu et al., 2007). Our findings, along
with other studies, raised an intriguing possibility that Wnt
morphogenic proteins may act upstream of the known Eomes-
IL-2Rb axis to confer cytokine responsiveness to memory
CD8+ T cells. The potential roles of Wnt agonists in regulating
immunological memory may be explored to improve vaccination
regimens and enhance tumor immunotherapy.
EXPERIMENTAL PROCEDURES
Animals and Infectious Agents
TCF-1 null mice, p45 TCF-1 isoform transgenic mice, and stabilized b-catenin
transgenic mice were as described (Ioannidis et al., 2001; Verbeek et al., 1995;
Xie et al., 2005). Thy1.1+ or Thy1.2+ OT-I TCR transgenic mice and B6.SJL
mice were from Jackson Laboratories. Attenuated or virulent LM-Ova, VacV-
Ova, and their usage were as described (Zhao et al., 2010). All the animals
were housed and handled according to protocols approved by the Institutional
Animal Care and Use Committee at the University of Iowa.
Cell Isolations and Flow Cytometry
Isolation and adoptive transfer of WT or Tcf7/ OT-I cells and infection of
B6.SJL recipients were described previously (Badovinac and Harty, 2007).
Isolation of lymphocytes from the livers and lungs was carried out via an estab-
lished protocol as described (Masopust et al., 2001). Identification and charac-
terization of antigen-specific T cells were performed via cell surface, intracel-
lular, or intranuclear staining according to standard protocols (Intlekofer et al.,
2007; Zhao et al., 2010). Detection of BrdU uptake and activated Caspsase-3/
7 was as described (Zhao et al., 2010). Detailed methods are in Supplemental
Experimental Procedures.
Chromatin Immunoprecipitation
Splenic CD8+ T cells were isolated from WT, Tcf7/, or b-catenin transgenic
mice, cross-linked, and sonicated to generate chromatin fragments as
previous described (Yu et al., 2010). The chromatin was immunoprecipitated
with antibodies against TCF-1 (C63D9) and TLE1/2/3/4 (both from Cell
Signaling Technology), b-catenin (clone 14, BD Biosciences), or respective
normal rabbit or mouse IgG. Each DNA segment of interest was quantitatively
determined by real-time PCR (Yu et al., 2010), and abundance of the segment
Immunity
TCF-1 Regulates Longevity of CD8 Memory T Cellsby an antibody was first normalized to that by control IgG, followed by normal-
ization to the Rag2 promoter region to calculate the relative enrichment for the
segment.
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